Dexcom Outlines Three-Pronged Growth Strategy To Reach $4-4.5BN Revenue Goal By 2025
Dexcom’s growth strategy includes growing its core business, expanding into pharmacy sales channel, and expanding into new markets.
You may also be interested in...
The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the second day of the meeting.
In this week’s podcast: LivaNova sells its heart valve business to a private equity firm, an expert panel discusses the challenges of addressing so-called “metabesity,” and Dexcom explains its plans to double its revenue over the next few years.
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.